esmolol has been researched along with cocaine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Brody, SL; Sand, IC; Slovis, CM; Wrenn, KD | 1 |
Pollan, S; Tadjziechy, M | 1 |
Parr, MJ | 2 |
Addison, D; Alam, M; Jneid, H; Kayani, W; Lakkis, N; Misra, A; Pham, D; Resar, J | 1 |
1 review(s) available for esmolol and cocaine
Article | Year |
---|---|
Outcomes of beta blocker use in cocaine-associated chest pain: a meta-analysis.
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Carvedilol; Cocaine; Humans; Metoprolol; Propanolamines; Propranolol | 2018 |
1 trial(s) available for esmolol and cocaine
Article | Year |
---|---|
Experience with esmolol for the treatment of cocaine-associated cardiovascular complications.
Topics: Adrenergic beta-Antagonists; Adult; Cardiovascular Diseases; Cocaine; Emergency Service, Hospital; Female; Georgia; Hemodynamics; Hospitals, Teaching; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Propanolamines; Substance-Related Disorders | 1991 |
4 other study(ies) available for esmolol and cocaine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Esmolol in the management of epinephrine- and cocaine-induced cardiovascular toxicity.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Cocaine; Epinephrine; Humans; Male; Middle Aged; Nasal Polyps; Propanolamines | 1989 |
Drug smuggler's delirium.
Topics: Adrenergic beta-Antagonists; Cocaine; Drug and Narcotic Control; Humans; Labetalol; Poisoning; Propanolamines | 1993 |
Cocaine dosage in rhinosurgery.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Cocaine; Humans; Labetalol; Propanolamines | 1993 |